EZZ Life Science Holdings Ltd. Financial Overview
EZZ Life Science Holdings Ltd.'s market cap is currently AU$68.17M. The company's EPS TTM is AU$0.075; its P/E ratio is 9.91; and it has a dividend yield of 2.76%. EZZ Life Science Holdings Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
